Related Experiment Video
Updated: Mar 21, 2026
03:38
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
2.0K
Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools
1Department of Chemistry, Pohang University of Science and Technology, Pohang, Gyeongbuk, South Korea.
Experimental & Molecular Medicine
|May 7, 2016
Summary
Aptamer-nanomaterial hybrids offer advanced biocompatibility and selectivity for disease diagnosis and therapy. This review covers aptamer screening (SELEX) and their applications in diagnostics and therapeutics, alongside conjugate designs.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Nanotechnology
Background:
- Accurate disease diagnosis and effective therapy are crucial for health.
- Cutting-edge technologies are vital for diagnosing and treating diseases.
- Aptamer-nanomaterial hybrids show promise due to biocompatibility, low immunogenicity, and selectivity.
Purpose of the Study:
- To review aptamer screening techniques, including Systematic Evolution of Ligands by Exponential Enrichment (SELEX).
- To present diagnostic and therapeutic applications of aptamers.
- To describe aptamer-nanomaterial conjugate designs and their uses in diagnosis and therapy.
Main Methods:
- Review of literature on aptamer screening methodologies.
- Analysis of aptamer-based diagnostic and therapeutic strategies.
- Examination of various aptamer-nanomaterial conjugate designs.
Main Results:
- Aptamers are versatile biomolecules with high target specificity.
- SELEX is a key method for aptamer discovery.
- Aptamer-nanomaterial hybrids enhance diagnostic sensitivity and therapeutic efficacy.
Conclusions:
- Aptamer-nanomaterial hybrids represent a significant advancement in medical diagnostics and therapeutics.
- Further research into conjugate designs can optimize clinical applications.
- These hybrids offer a promising platform for personalized medicine.
